Who
Dragan Cicic
SVP, Chief Development Officer
Company insider
Files Form 4 as: SVP, Chief Development Officer, SELLAS Life Sciences Group; Chief Technology Officer, Actinium Pharmaceuticals, Inc. (Delaware).
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Feb 2014
- Last trade
- 7 Jan 2026
- Last filed
- 9 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jan 2026filed 9 Jan 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code J | $96K63,800 at $1.50 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —169,500 at $0.00 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —113,000 at $0.00 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —81,300 at $0.00 | filing |
| 4 Dec 2024filed 5 Dec 2024 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code J | $9,3298,256 at $1.13 | filing |
| 14 Mar 2017filed 16 Mar 2017 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $104K75,000 at $1.39 | filing |
| 15 Apr 2016filed 18 Apr 2016 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $100K50,000 at $1.99 | filing |
| 7 May 2015filed 22 May 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code F | $1,411560 at $2.52 | filing |
| 7 May 2015filed 22 May 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code D | $5,9982,380 at $2.52 | filing |
| 7 May 2015filed 22 May 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $7,2422,874 at $2.52 | filing |
| 18 Feb 2015filed 16 Mar 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $125K35,000 at $3.58 | filing |
| 21 Feb 2014filed 16 Mar 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)Biotechnology | SEC FORM 4 Code A | $19K3,500 at $5.55 | filing |
| 21 Feb 2014filed 16 Mar 2015 | ATNM Actinium Pharmaceuticals, Inc. (Delaware)option or derivative · Biotechnology | SEC FORM 4 Code A | $175K31,500 at $5.55 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.